394 related articles for article (PubMed ID: 22217457)
1. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
[TBL] [Abstract][Full Text] [Related]
2. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
[TBL] [Abstract][Full Text] [Related]
3. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.
De Luca G; Suryapranata H; de Boer MJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Ernst N; van 't Hof AW;
Int J Cardiol; 2007 Apr; 117(2):232-7. PubMed ID: 16899313
[TBL] [Abstract][Full Text] [Related]
4. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
6. Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction.
Armstrong PW; Mahaffey KW; Chang WC; Weaver WD; Hochman JS; Theroux P; Rollins S; Todaro TG; Granger CB;
Am Heart J; 2006 Apr; 151(4):787-90. PubMed ID: 16569534
[TBL] [Abstract][Full Text] [Related]
7. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
[TBL] [Abstract][Full Text] [Related]
8. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Patel MR; Westerhout CM; Granger CB; Brener SJ; Fu Y; Siha H; Kim RJ; Armstrong PW
Am Heart J; 2013 Feb; 165(2):226-33. PubMed ID: 23351826
[TBL] [Abstract][Full Text] [Related]
9. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
Mahaffey KW; Granger CB; Nicolau JC; Ruzyllo W; Weaver WD; Theroux P; Hochman JS; Filloon TG; Mojcik CF; Todaro TG; Armstrong PW;
Circulation; 2003 Sep; 108(10):1176-83. PubMed ID: 12925455
[TBL] [Abstract][Full Text] [Related]
10. [Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].
Wang JG; Kong DQ; Huang Y; Huang JY; Zhang ZL; Wu WC; Pan XW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):333-6. PubMed ID: 19570336
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing acute myocardial infarction in patients with left bundle branch block.
Lopes RD; Siha H; Fu Y; Mehta RH; Patel MR; Armstrong PW; Granger CB
Am J Cardiol; 2011 Sep; 108(6):782-8. PubMed ID: 21726838
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Tjandrawidjaja MC; Fu Y; Westerhout CM; Wagner GS; Granger CB; Armstrong PW;
Am J Cardiol; 2010 Sep; 106(5):630-4. PubMed ID: 20723636
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
14. Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction.
Di Chiara A; Plewka M; Werren M; Badano LP; Fresco C; Fioretti PM
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):340-6. PubMed ID: 16645412
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.
Leonardi S; Stebbins A; Lopes RD; Lokhnygina Y; Todd M; Bhatt DL; Stone GW; Lincoff AM; Dauerman HL; Gibson CM; White HD; Parikh KH; Gruberg L; Herrmann HC; McLaurin BT; Goodman SG; Mahaffey KW
Coron Artery Dis; 2013 Jun; 24(4):321-7. PubMed ID: 23442944
[TBL] [Abstract][Full Text] [Related]
16. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
[TBL] [Abstract][Full Text] [Related]
18. Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.
Hallén J; Sejersten M; Johanson P; Atar D; Clemmensen PM
Am J Cardiol; 2010 May; 105(9):1223-8. PubMed ID: 20403470
[TBL] [Abstract][Full Text] [Related]
19. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
20. Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Kaul P; Fu Y; Westerhout CM; Granger CB; Armstrong PW
Am J Cardiol; 2012 Dec; 110(11):1555-60. PubMed ID: 22920928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
